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brain injury is caused by the development
of inflammation at the site of infarction.
Proteasome inhibitors block inflammation
bypreventing proteasome-dependent ac-
tivation of transcription factor NF-kB. The
study from the Crews group demonstrat-
ing neurotropic properties of proteasome
inhibitors (Hines et al., 2008) suggests
that an increase in NGF production can
also contribute to this effect. This should
stimulate the interest in continuation of
clinical testing of proteasome inhibitors
in stroke patients.
Finally, we would like to draw the
readers’ attention to the fact that all the
inhibitors discussed in these articles are
natural products, as are the well-known
proteasome inhibitors lactacystin, epoxo-
micin, and salinosporamide A, and the
less famous eponemycin, tyropeptin A
(Momose et al., 2005), and TMC-95. If pro-
teasome inhibitors are classified based on
chemical mechanisms, by which they in-
hibit the proteasome, sevenmajor classes
can be distinguished (Figure 1). Classes
represented by natural products outnum-
ber thosedevelopedbyorganic synthesis.
Indeed, four of these classes (b-lactones,
peptide epoxyketones, cyclic peptides,
and macrocyclic peptide vinyl ketones)
were discovered as natural products. Nat-
ural products are represented in the fifth
class, peptide aldehydes, although these
compounds (e.g., MG132) were initially
developed by chemical synthesis. Only
two classes of inhibitor (peptide boro-
nates, e.g., bortezomib, and peptide vinyl
sulfones) do not yet have natural products
among them. Clearly, micro-organisms
learned of the importance of the protea-
some to their hosts long before scientists
discovered this fascinating particle. We
predict that this trend of discovery of pro-
teasome inhibitors among natural prod-
ucts will continue, and hold hope that
some of new inhibitors will open novel
therapeutic applications for these com-
pounds as the study by the Crews group
suggests.
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The de novo design of enzymes with activities not found in natural biocatalysts is a major challenge for mo-
lecular biology. Sophisticated computational methods have recently led to impressive progress in this excit-
ing and rapidly evolving field (Ro¨thlisberger et al., 2008; Jiang et al., 2008).Natural evolutionhasyieldedenzymeswith
well-defined active sites in which virtually
all metabolic reactions are catalyzed with
high efficiency and specificity. It has been
a major goal of biochemistry for the past
century to understand the chemical and
molecular principles of these extremely
precise and exquisitemolecularmachines.
Recently, technical advances in molecular
biology have led to a renaissance in enzy-
mology by enabling researchers to modify
at will the activities and stabilities of manynaturally occurring enzymes. This rapidly
emerging field of ‘‘enzyme design’’ has
provided new insights in the structure-
function relationships of molecular bio-
catalysts. Moreover, these approaches
have facilitated the generation of stabilized
enzymeswith increased turnover numbers
andaltered substrate- and stereo-selectiv-
ities to be used in industrial processes
(Toscano et al., 2007).
Until now, the most impressive results
in enzyme design have been obtained byChemistry & Biology 15, May 200‘‘directed evolution.’’ In this two-step ap-
proach random mutagenesis is used to
create large enzyme repertoires, from
which optimized variants are then isolated
using either selection or screening tech-
niques (Bloom et al., 2005). In contrast
to directed evolution, the alternative ap-
proach of ‘‘rational’’ enzyme design re-
quires a detailed knowledge of a specific
enzyme structure and catalytic mecha-
nism (Woycechowsky et al., 2007). Al-
though occasionally successful, rational8 ª2008 Elsevier Ltd All rights reserved 421
Chemistry & Biology
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A model for the proposed active site is created initially based upon the geometric constraints dictated by
the expected transition state structure for the reaction to be catalyzed. Existing protein scaffolds that are
compatible with the idealized active site are selected with RosettaMatch. The optimized designs are
tested experimentally after synthesis of the genes required for expression of the designed enzymes. Those
enzyme variants with catalytic activity are further enhanced via directed evolution. The information gath-
ered from the directed evolution experiments can be incorporated into improvements within the initial
design algorithms.design approaches often fail, due to a lim-
ited understanding of the subtle interplay
among amino acid side chains within an
enzyme active site.
Two recently published papers by Da-
vid Baker and colleagues suggest that
this bottleneck toward the acquisition of
tailored enzymes can be overcome by
applying sophisticated computational
methods (Ro¨thlisberger et al., 2008; Jiang
et al., 2008). The approach used by these
authors is outlined in Figure 1.
Inoneexample, computationalmethods
were applied to thedesign of enzymes that
will catalyze theKempelimination,which is
a nonnatural model reaction during which
proton abstraction from a carbon must
be mediated by a general base (Ro¨thlis-
berger et al., 2008). First, the authors de-
signed two idealized active sites, which
contained either an aspartate/glutamate,
or a histidine-aspartate dyad as the cata-
lytic base. Forbothsites, functional groups
were then added to facilitate transition
state (TS) stabilization, and their place-
ment and orientation was optimized us-
ing quantum mechanical and classical422 Chemistry & Biology 15, May 2008 ª200methods. In the next step, a large set of
stable protein scaffolds with known X-ray
structures was scanned to find backbone
positions, which could harbor these ideal-
ized active sites. To this end, a generalized
version of the program RosettaMatch
(Zanghellini et al., 2006) was used, which
is based on the RosettaDesign algorithm.
RosettaDesign optimizes the packing of
residues on a given backbone by combin-
ing side-chain orientations for the various
amino acids deposited in a rotamer library.
RosettaMatchassesses thequalityofade-
sign bymeans of amultiparameter scoring
function, and ranks in a given backbone
many different active site locations on the
basis of catalytic geometry and TS energy.
Out of the more than 105 initial Kemp
elimination designs, 59 were experimen-
tally tested. Eight of the designs, which
contained between 10 and 20 residue ex-
changes, showed weak enzymatic activity
with catalytic efficiencies (kcat/KM) be-
tween 6 and 160 M-1s-1, and rate acceler-
ations (kcat/kuncat) of up to 2.5 3 10
5 fold.
The X-ray structure of one of the variants
was solved and the active site superim-8 Elsevier Ltd All rights reservedposes with a root mean square deviation
of 0.95 A˚ with the calculated active site
model. Moreover, the back-mutation of
the introduced bona fide catalytic bases
in several designs abolished or strongly re-
duced catalytic activity, which suggests
that the new enzymes catalyzed the
Kemp elimination with the expected reac-
tion mechanism. In order to further im-
prove catalytic activity, seven roundsof di-
rected evolution were performed with the
enzyme for which the X-ray structure had
beendetermined. Thebest variant isolated
by this approach showed a >200-fold im-
provement in activity compared to the
starting enzyme, reaching a respectable
kcat/Kmof 2600M
-1s-1. Theeight additional
exchangesweremainlyclusteredadjacent
to the designed residues, suggesting that
the beneficial effects of these new resi-
dues are due to subtle fine-tuning of the
active site geometry.
Inasecondproject, theauthorsdesigned
enzymes for a chemicallymore demanding
retro-aldol reaction, which requires the
breakingof a carbon-carbonbond inanon-
natural substrate (Jiang et al., 2008). Since
this reaction proceeds in several steps,
a composite active site had to bemodeled,
that would simultaneously accommodate
multiple intermediates and TS. This chal-
lenge was met by modifying the enzyme
design methodology. First, the various re-
action intermediates and transition states
were modeled in the context of a specific
set of functional residues. These models
were superimposed resulting in four alter-
native composite active site motifs, all of
which comprised a nucleophilic lysine and
general acid/base groups to catalyze vari-
ous proton transfer steps. For each motif,
large sets of discrete 3Dmodels were gen-
eratedbyvaryingdegreesof freedomof the
composite TS, the orientation of catalytic
sitechains relative to theTSand theconfor-
mation of the side chains. RosettaMatch
was then used to identify candidate cata-
lytic site locations in a number of different
scaffolds. Following a further optimization
and an assessment of the models, 72 of
them with 8–20 amino acid changes in 10
different scaffolds were experimentally
tested. Altogether, 32 designs showed
weak catalytic activity. Interestingly, the
most active designs contained an explicitly
modeled water molecule, which is as-
sumed to be involved in catalysis by stabi-
lizing a reaction intermediate and acting
as a general base. The X-ray structure of
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changes largely confirmed the active site
design. Nevertheless, it displayed only
modest catalytic activity, with one mole-
cule of product generated in 2 hr and an
apparent catalytic efficiency (kcat/KM) of
0.74 M-1s-1.
From the large variety of protein scaf-
folds that were computationally scanned
to harbor the Kemp elimination and the
retro-aldol designs, only very few folds
turned out to be suitable hosts for these
reactions. Among them, the most prom-
inent ones were two members of the
(ba)8- or TIM barrel family, which is the
most frequent and versatile fold among
naturally occurring enzymes (Gerlt and
Raushel, 2003; Sterner and Ho¨cker,
2005), and it is interesting to note that
the computational design shows the
same fold preference as found in nature.
Although the work reported here
shows that computational enzyme de-
sign is feasible, the catalytic activities of
the newly generated artificial enzymes
are much lower than those evolved by
nature. In this context it is interesting to
compare the turnover numbers and cata-
lytic efficiencies of the Kemp elimination
and the retro-aldol designs with those
of catalytic antibodies. For the Kemp
elimination, the Hilvert group has isolated
a catalytic antibody (34E4) with a kcat/Km
of 5.4 3 103 M-1 s-1 and has also shown
that this reaction can be catalyzed bybovine serum albumin (BSA) with a cata-
lytic efficiency of 2.4 3 101 M-1 s-1 (Hu
et al., 2004). Thus, the adventitious cata-
lytic activity of BSA with the Kemp sub-
strate compares quite favorably with the
best designed enzyme while the more
optimized catalytic antibody outper-
formed the best designed enzyme even
after seven additional rounds of random
mutagenesis. Catalytic antibodies have
also been characterized by the groups
of Barbas and Lerner for the retro-aldol
reaction. The 38C2 antibody catalyzed
the cleavage of the test substrate with
a kcat of 1.0 min
-1 and kcat/Km of 1.1 3
103 M-1 s-1 (List et al., 1998). Thus, the
catalytic antibody is a better catalyst by
2–3 orders of magnitude. Notably absent
from the discussion of the catalytic profi-
ciency of the retro-adolase is an assess-
ment of the stereoselectivity for the tar-
get substrate. The target substrate has
a chiral center at C-4 and it would have
been of significant interest to learn
whether or not the catalytically active
proteins preferentially cleaved either the
R- or S-enantiomers and whether this
preference derived from their initial de-
sign elements. Thus, it remains to be
seen whether de novo designed en-
zymes will be able to ever rival those op-
timized by Mother Nature. The results of
the Kemp elimination reaction design
suggest that the best strategy to reach
this ambitious goal in the near termChemistry & Biology 15, May 200would be to combine computational ap-
proaches with directed evolution.
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